Skip to content

APOTHEEK PYLYSER SOFIE: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK PYLYSER SOFIE

BE 0888.396.472
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€58,214
2024 · €50,386+€7,827
Equity
€84,627
2024 · €146,413-€61,786
Cash
€14,177
2024 · €17,790-€3,612
Balance sheet total
€314,905
2024 · €295,429+€19,476

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€31,128

    up €31,128 (+22.8%), from €136,547 to €167,675

    of which Trade receivables: +€43,282

  • Stocks and contracts -€10,053

    down €10,053 (-7.2%), from €138,860 to €128,807

  • Cash -€3,612

    down €3,612 (-20.3%), from €17,790 to €14,177

    mainly Contributions, distributions and other (-€120,000) and Receivables within one year (-€31,128)

Equity and liabilities
  • Other debts +€77,175

    up €77,175 (+68.7%), from €112,283 to €189,459

  • Reserves -€61,786

    down €61,786 (-53.1%), from €116,413 to €54,627

Income statement
  • Gross operating margin +€4,978

    up €4,978 (+6.6%), from €75,879 to €80,857

  • Financial charges -€4,598

    down €4,598 (-75.7%), from €6,074 to €1,476

  • Taxes +€1,818

    up €1,818 (+12.1%), from €15,029 to €16,848

  • Write-downs -€1,052

    down €1,052 (-13.5%), from €7,795 to €6,744

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €50,386
Gross operating margin +€4,978
Depreciation -€149
Write-downs +€1,052
Other operating charges -€60
Financial income -€773
Financial charges +€4,598
Taxes -€1,818
Result 2025 €58,214

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€119,060
Investment -€2,673
Financing -€120,000
Cash 2024 €17,790
Net result for the year +€58,214
Depreciation +€1,532
Stocks and contracts +€10,053
Receivables within one year -€31,128
Deferred charges and accrued income -€872
Trade debts +€1,749
Tax, wage and social debts +€2,338
Other debts +€77,175
Investment in fixed assets (net) -€2,673
Contributions, distributions and other -€120,000
Cash 2025 €14,177
Every line side by side 39 lines
Line Code 2024 2025 Change %
Total assets 20/58 €295,429 €314,905 +€19,476 +6.6%
Fixed assets 21/28 €2,233 €3,374 +€1,140 +51.1%
Tangible fixed assets 22/27 €2,233 €3,374 +€1,140 +51.1%
Plant, machinery and equipment 23 €1,326 €530 -€797 -60.1%
Furniture and vehicles 24 €907 €2,844 +€1,937 +213.6%
Current assets 29/58 €293,196 €311,532 +€18,336 +6.3%
Stocks and contracts in progress 3 €138,860 €128,807 -€10,053 -7.2%
Stocks 30/36 €138,860 €128,807 -€10,053 -7.2%
Amounts receivable within one year 40/41 €136,547 €167,675 +€31,128 +22.8%
Trade receivables 40 €5,416 €48,698 +€43,282 +799.2%
Other amounts receivable 41 €131,131 €118,977 -€12,154 -9.3%
Cash at bank and in hand 54/58 €17,790 €14,177 -€3,612 -20.3%
Deferred charges and accrued income 490/1 €0 €872 +€872
Total equity and liabilities 10/49 €295,429 €314,905 +€19,476 +6.6%
Equity 10/15 €146,413 €84,627 -€61,786 -42.2%
Contributions 10/11 €30,000 €30,000 = 0.0%
Reserves 13 €116,413 €54,627 -€61,786 -53.1%
Distributable reserves 133 €116,413 €54,627 -€61,786 -53.1%
Profit (loss) carried forward 14 - €0 =
Amounts payable 17/49 €149,016 €230,279 +€81,263 +54.5%
Amounts payable within one year 42/48 €149,016 €230,279 +€81,263 +54.5%
Trade debts 44 €23,886 €25,635 +€1,749 +7.3%
Suppliers 440/4 €23,886 €25,635 +€1,749 +7.3%
Taxes, remuneration and social security 45 €12,847 €15,185 +€2,338 +18.2%
Taxes 450/3 €12,847 €15,185 +€2,338 +18.2%
Other amounts payable 47/48 €112,283 €189,459 +€77,175 +68.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,383 €1,532 +€149 +10.8%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €7,795 €6,744 -€1,052 -13.5%
Other operating charges 640/8 €513 €574 +€60 +11.8%
Gross operating margin 9900 €75,879 €80,857 +€4,978 +6.6%
Operating profit (loss) 9901 €66,187 €72,008 +€5,821 +8.8%
Financial income 75/76B €5,302 €4,530 -€773 -14.6%
Recurring financial income 75 €5,302 €4,530 -€773 -14.6%
Financial charges 65/66B €6,074 €1,476 -€4,598 -75.7%
Recurring financial charges 65 €6,074 €1,476 -€4,598 -75.7%
Profit (loss) for the period before taxes 9903 €65,416 €75,061 +€9,646 +14.7%
Income taxes 67/77 €15,029 €16,848 +€1,818 +12.1%
Profit (loss) for the period 9904 €50,386 €58,214 +€7,827 +15.5%
Profit (loss) for the period to be appropriated 9905 €50,386 €58,214 +€7,827 +15.5%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.